[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[2] Matsuda T, Saika K. The 5-year relative survival rate of stomach cancer in the USA, Europe and Japan[J]. Jpn J Clin Oncol, 2013,43(11):1157-1158.
[3] Cunningham D, Chua YJ. East meets west in the treatment of gastric cancer[J]. N Engl J Med, 2007, 357(18): 1863-1865.
[4] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[5] Li WQ, Pan KF, Zhang Y, et al. RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population[J]. Carcinogenesis, 2011, 32(3):406-410. [6] Wang K, Kan J, Yuen ST, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer [J]. Nat genet, 2011, 43(12):1219-1223.
[7] Zeng HM, Pan KF, Zhang Y, et al. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20(12):2594-2602.
[8] Chang W, Ma L, Lin L, et al. Identification of novel hub genes associated with liver metastasis of gastric cancer[J]. Int J Cancer, 2009, 125(12):2844-2853.
[9] Nathan C, Ding A. Nonresolving inflammation[J]. Cell, 2010, 140(6):871-882.
[10] Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer:analysis of individual patient data from randomised trials[J]. Lancet, 2011, 377(9759):31-41.
[11] Chang W, Du Y, Zhao X, et al. Inflammation-related factors predicting prognosis of gastric cancer[J]. World Journal of Gastroenterology, 2014, 20(16): 4578-4588.
[12] Kodama M, Murakami K, Okimoto T, et al. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation[J]. Digestion, 2012, 85(2):126-130.
[13] Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers[J]. J Clin Oncol, 2010, 28(26):4045-4051.
[14] de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development[J]. Nat Rev Cancer,2006,6(1): 24-37.
[15] Lee KS, Kalantzis A, Jackson CB, et al. Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3γ via gastric STAT3 activation[J].PLoS One, 2012, 7(2):e30786.
[16] Xiong H, Du W, Wang JL, et al. Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer[J]. J Mol Med, 2012, 90(9):1037-1046.
[17] Liang H, Kim YH. Identifying molecular drivers of gastric cancer through next-generation sequencing[J]. Cancer Lett, 2013, 340(2):241-246.
[18] Corso G, Carvalho J, Marrelli D, et al. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer[J]. J Clin Oncol, 2013, 31(7):868-875.
[19] Li WQ, Zhang L, Ma JL, et al. Association between genetic polymorphisms of DNA base excision repair genes and evolution of precancerous gastric lesions in a Chinese population[J]. Carcinogenesis, 2009, 30(3):500-505.
[20] Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions[J]. Gut, 2012, 61(6):812-818.
[21] Shiotani A, Murao T, Kimura Y, et al. Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer[J]. Br J Cancer, 2013, 109(9):2323-2330.
[22] Ueda T,Volinia S,Okumura H, et al.Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis[J]. Lancet Oncol, 2010, 11(2):136-146.
[23] Karin M. Nuclear factor-kappaB in cancer development and progression[J]. Nature, 2006, 441(7092):431-436.
[24] 赵海滨,张伟杰,周志华,等. MMP-7、MMP-9、VEGF-C、VEGF-D在胃癌中的表达及其临床意义[J]. 东南国防医药,2010,12(3):197-199.
[25] 徐桂芳,张建东,赵海滨,等. E-钙粘蛋白和MMP-9在胃癌组织中的表达及其临床意义[J]. 东南国防医药,2010,12(4):308-311, 321.
[26] Wu CY, Wu MS, Kuo KN, et al. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients[J]. J Clin Oncol, 2010, 28(18):2952-2957.
[27] Abnet CC, Freedman ND, Kamangar F, et al. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis[J]. Br J Cancer, 2009, 100(3):551-557.
[28] Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer[J]. Gastroenterology, 2011, 140(6):1807-1816.
[29] Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials[J]. Lancet, 2011, 377(9759):31-41.
[30] Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and helicobacter pylori eradication on precancerous gastric lesions[J]. Gut, 2012, 61(6):812-818.
[31] Thiel A, Mrena J, Ristimki A. Cyclooxygenase-2 and gastric cancer[J]. Cancer Metastasis Rev, 2011, 30(3-4):387-395.
[32] Han Y, Cai H, Ma L, et al. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy[J]. Cancer, 2013, 119(19): 3436-3445.
[33] Villanueva A, Hoshida Y, Battiston C, et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma[J]. Gastroenterology, 2011, 140(5):1501-1512.
[1]刘挺松,宫剑滨,程训民,等.波动性高糖对人脐静脉内皮细胞炎症因子表达的影响[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):209.[doi:10.3969/j.issn.1672-271X.2013.03.001]
LIU Ting-song,GONG Jian-bin,CHENG Xun-min,et al.Impact of oscillating high glucose on pro-inflammatory cytokines expression in human umbilical vein endothelial cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(03):209.[doi:10.3969/j.issn.1672-271X.2013.03.001]
[2]王晨光,傅芬兰,张鹏程,等.全胃切除术后早期肠内外营养的临床研究[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):30.
WANG Chen-guang,FU Fen-lan,ZHANG Peng-chen,et al.Evaluation of early parenteral nutrition and enteral nutrition in totalgastrectomy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(03):30.
[3]杜振双,张诚华.BillrothⅡ式胃切除术对患者血糖的影响[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):62.
[4]林夏雯,李爱梅,施 鸣,等.部分胃癌PET-CT显像与HIF-1α等指标的相关分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):407.
LIN Xia-wen,LI Ai-mei,SHI Ming,et al.Analysis of relationship among HIF-1α,COX-2,VEGF and SUVmax in gastric cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(03):407.
[5]房文铮,陈锦华,欧阳学农.香菇多糖腹腔灌注联合热化疗治疗进展期胃癌[J].医学研究与战创伤救治(原医学研究生学报),2010,12(02):148.
[6]赵海滨,张伟杰,周志华,等.MMP-7、MMP-9、VEGF-C、VEGF-D在胃癌中的表达及其临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):197.
ZHAO Hai-bin,ZHANG Wei-jie,ZHOU Zhi-Hua,et al.Expression and significance of MMP-7, MMP-9, VEGF-C, and VEGF-D in gastric carcinomas[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(03):197.
[7]徐桂芳,张建东,赵海滨,等.E-钙粘蛋白和MMP-9在胃癌组织中的表达及其临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):308.
XU Gui-fang,ZHANG Jian-dong,ZHAO Hai-bin,et al.Expression and significance of E-Cadherin and matrix metalloproteinase-9 in gastric carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(03):308.
[8]仇学明,杜云翔,罗红来,等.ZnPPⅨ对胃癌腹膜转移细胞凋亡的影响[J].医学研究与战创伤救治(原医学研究生学报),2009,11(06):495.
QIU Xue-ming,DU Yun-Xiang,LUO Hong-lai,et al.Effect of ZnPPⅨ on apoptosis of human gastric cancer cell line with peritoneal metastasis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(03):495.
[9]徐 萍,唐永明.端粒酶活性在胃癌组织中表达的临床意义[J].医学研究与战创伤救治(原医学研究生学报),2009,11(06):518.
XU Ping,TANG Yong-ming.The clinical significance of expression of telomerase in gastric cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(03):518.
[10]杨 聪,黄 谦,吴彦民.胆汁反流与胃癌的关系研究现状[J].医学研究与战创伤救治(原医学研究生学报),2008,10(01):37.